These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 25162218

  • 1. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
    Hoffer E, Kurnik D, Efrati E, Scherb I, Karasik M, Ring G, Bentur Y.
    Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of QMS everolimus assay using Indiko analyzer: comparison with an ultra-performance liquid chromatography-tandem mass spectrometry method.
    Buthiau D, Bargnoux AS, Badiou S, Sutra T, Dupuy AM, Pageaux GP, Mourad G, Cristol JP.
    Ther Drug Monit; 2015 Apr; 37(2):275-8. PubMed ID: 25254414
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study.
    Schniedewind B, Niederlechner S, Galinkin JL, Johnson-Davis KL, Christians U, Meyer EJ.
    Ther Drug Monit; 2015 Jun; 37(3):296-303. PubMed ID: 25970506
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of QMS everolimus assay using Hitachi 917 Analyzer: comparison with liquid chromatography/mass spectrometry.
    Dasgupta A, Davis B, Chow L.
    Ther Drug Monit; 2011 Apr; 33(2):149-54. PubMed ID: 21266941
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
    Moes DJ, Press RR, de Fijter JW, Guchelaar HJ, den Hartigh J.
    Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus Monitoring in Liver Transplant Recipients, Posttransplant Cholestasis: A Comparative Between 2 Commercial Immunoassays and a Liquid Chromatography-Tandem Mass Spectrometry Method.
    Parant F, Delignette MC, Charpiat B, Lacaille L, Lebosse F, Monneret G, Mohkam K, Mabrut JY, Aubrun F, Heyer L, Antonini T.
    Ther Drug Monit; 2024 Aug 01; 46(4):446-455. PubMed ID: 38648663
    [Abstract] [Full Text] [Related]

  • 13. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.
    Verstraete AG, Rigo-Bonnin R, Wallemacq P, Vogeser M, Schuetzenmeister A, Schmiedel C, Shipkova M.
    Ther Drug Monit; 2018 Feb 01; 40(1):59-68. PubMed ID: 29210975
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M, Di Stasio E, Basile MR, Elisei F, Antonini M, Ettorre GM, Iappelli M, Pucillo LP.
    Ther Drug Monit; 2013 Feb 01; 35(1):96-100. PubMed ID: 23191996
    [Abstract] [Full Text] [Related]

  • 17. Comparison of a stable isotope-labeled and an analog internal standard for the quantification of everolimus by a liquid chromatography-tandem mass spectrometry method.
    Heideloff C, Payto D, Wang S.
    Ther Drug Monit; 2013 Apr 01; 35(2):246-50. PubMed ID: 23503452
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive drugs in whole blood: validation of a commercially available liquid chromatography/tandem mass spectrometry kit and comparison with immunochemical assays.
    Polledri E, Mercadante R, Ferraris Fusarini C, Maiavacca R, Fustinoni S.
    Rapid Commun Mass Spectrom; 2017 Jul 15; 31(13):1111-1120. PubMed ID: 28439923
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the everolimus concentrations measured in whole blood with everolimus QMS or sirolimus CMIA.
    Capone D, Cataldi M, Guida B, Mosca T, Tarantino G.
    Scand J Clin Lab Invest; 2018 Jul 15; 78(4):275-280. PubMed ID: 29575933
    [Abstract] [Full Text] [Related]

  • 20. Comparison of whole-blood sirolimus concentrations measured by EMIT-based Siemens Viva-ProE® System and LC-MS/MS in Chinese transplant patients.
    Lin R, Cai Y, Huang Y, Li X, Chen Y, Chen B, Lai K, Wu J, Cheng Y, Liu M, Chen Y, Qiu H.
    J Pharm Biomed Anal; 2024 Sep 01; 247():116271. PubMed ID: 38850850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.